Is Oncolys BioPharma Inc. (4588.T) a Buy, Sell, or Hold?
JPX : 4588.T
Oncolys BioPharma Inc. — Earnings Estimates
$2741 JPY
$71 (2.66%)
- Volume
- 534.1K
- Average Volume
- 1.26M
- Market Capitalization
- $68.22B
- P/E Ratio
- -43.32
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3695.00
- Year Low
- $571.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.12
Annual earnings financials
4588.T financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
4588.T Estimated and Actual Revenue by Quarter
4588.T Estimated and Actual EPS by Quarter
4588.T Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2024-12-31 | 1 | -31000 | -31000 | -31000 | -31000 | -31000 | -31000 |
| 2023-12-30 | 1 | -1M | -1M | -1M | -1M | -1M | -1M |
4588.T Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2024-12-31 | 1 | - | - | - | 534K | 534K | 534K |
| 2023-12-30 | 1 | - | - | - | 13.71M | 13.71M | 13.71M |
4588.T Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2024-12-31 | 1 | 31000 | 31000 | 31000 | 0 | 0 | 0 | 0 |
| 2023-12-30 | 1 | 1M | 1M | 1M | 0 | 0 | 0 | 0 |